Live Breaking News & Updates on Positive topline results

Stay updated with breaking news from Positive topline results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates

Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , Cambridge , Cambridgeshire , United-kingdom , American , Ben-zeskind , Gina-nugent , Laurence-watts , Thomasj-schall , Drug-administration , Exchange-commission , Amgen

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

06.05.2024 - - Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) - - Initiation of Phase 2 clinical trial for RT-102 for the treatment of osteoporosis expected in 2024 - - RaniPill HC to be ready for ...

Talat-imran , Rani-therapeutics-holdings-inc , Exchange-commission , Celltrion-inc , Development-of-ranipill , Therapeutics-holdings , Chief-executive-officer , Subsequent-highlights , Positive-topline-results , Oral-anti-interleukin , Term-milestone-expectations , Private-securities-litigation-reform-act

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Lisbon , Lisboa , Portugal , Scotland , Martin-maron , Cytokinetics-diane-weisersenior , Mary-ellen-jay , Gregory-lewis , Scotland-inherited-cardiac-conditions-service , Cytokinetics-incorporated , Linkedin

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024…

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024…
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Cytokinetics-incorporated , Primary-results , Positive-topline-results , Obstructive-hypertrophic , Additional-analyses , Exercise-capacity , Late-breaking ,

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany , United-states , Munich , Bayern , German , Nielsc-riedemann , Laurie-doyle , Regina-lutz , Thomas-taapken , Katja-arnold , Drug-administration , Inflarx-pharmaceuticals-inc

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update

Single ascending dose (SAD) Phase I data confirm best-in-class potential of orally available C5aR inhibitor INF904; multiple ascending dose (MAD) ...

Germany , United-states , Munich , Bayern , German , Thomas-taapken , Nielsc-riedemann , Regina-lutz , Laurie-doyle , Katja-arnold , Inflarx-stops-development-of-vilobelimab , Inflarx-pharmaceuticals-inc

Suven Life Sciences : October 30, 2023Suven Life Sciences announces Positive Topline Results from a Phase-2 study evaluating Samelisant -October 30, 2023 at 06:31 am EDT

CSD/BSE&NSE/PR/2023-2024

October 30, 2023

To

...

Washington , United-states , Bandra , Maharashtra , India , Mumbai , Canada , Hyderabad , Andhra-pradesh , Telangana , Venkat-jasti , Shrenik-soni

Better Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

Advanced preparations for potential commercial launch of BT-001 in U.S. in mid-2023

Reported positive topline results from exploratory trial for fatty liver disease

Announced restructuring and... | March 30, 2023

United-states , Americans , American , Frank-karbe , Drug-administration , American-heart-association , Company-announces-restructuring-to-preserve-cash-runway , Nasdaq , Better-therapeutics-inc , World-evidence-program , American-college-of-cardiology , Exchange-commission

Stock Market | Daily Herald

Stock Market | Daily Herald
dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.

Iceland , Singapore , Norway , Australia , United-states , United-kingdom , Texas , Brazil , California , Liechtenstein , Washington , Russia

Finch Therapeutics Reports Fourth Quarter and Full Year

SOMERVILLE, Mass., March 31, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage...

Marc-blaustein , Mark-smith , Greg-perry , American-college-of-gastroenterology , Finch-therapeutics-group-inc , Ulcerative-colitis-development-program-to-takeda , Clinical-development , Therapeutics-group , Human-first-discovery , Chief-executive-officer , Chief-financial-officer , Chief-operating-officer